Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This AI Wellness Platform Is Scaling Fast (click to learn more) A Closer Look at Cannabis Company HERB (click to learn more) Sranan Acquires Lawantino Gold Project Along the Prolific Antino-Sela Creek Trend (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News ChitogenX Inc C.CHGX

Alternate Symbol(s):  CHNXF

Healthcare Biotechnology
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho... see more

Recent & Breaking News (CSE:CHGX)

CHITOGENX ANNOUNCES SIGNING OF BINDING LETTER OF INTENT WITH OLIGO MEDIC INC., ISSUANCE OF PARTIAL REVOCATION ORDER, AND FINANCING

Canada NewsWire September 9, 2025

CSE Bulletin: Suspensions - CHGX, SHP, TYUM

Newsfile June 9, 2025

Canadian Investment Regulatory Organization Trading Halt - CHGX

Canada NewsWire June 9, 2025

Canadian Investment Regulatory Organization Trade Resumption - CHGX

Canada NewsWire February 27, 2025

Canadian Investment Regulatory Organization Trading Halt - CHGX

Canada NewsWire February 24, 2025

CHITOGENX REPORTS THIRD QUARTER 2025 RESULTS

Canada NewsWire December 23, 2024

CHITOGENX REPORTS SECOND QUARTER 2025 RESULTS

Canada NewsWire September 30, 2024

CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS

Canada NewsWire July 18, 2024

CHITOGENX REPORTS FIRST QUARTER 2025 RESULTS

Canada NewsWire July 2, 2024

CHITOGENX REPORTS 2024 FISCAL YEAR-END RESULTS

Canada NewsWire May 28, 2024

CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Canada NewsWire February 28, 2024

CHITOGENX REPORTS THIRD QUARTER 2024 RESULTS

Canada NewsWire January 3, 2024

CHITOGENX DEMONSTRATES ORTHO-R EFFICACY AND OSTEOARTHRITIS PROTECTION IN LARGE ANIMAL MENISCAL REPAIR STUDY

Canada NewsWire November 9, 2023

CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM

PR Newswire November 7, 2023

CHITOGENX REPORTS SECOND QUARTER 2024 RESULTS

Canada NewsWire September 29, 2023

CHITOGENX RECEIVES NOTICE OF ALLOWANCE FOR KEY PATENT IN UNITED STATES AND CANADA

Canada NewsWire September 28, 2023

CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

Canada NewsWire September 26, 2023

CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS

Canada NewsWire August 2, 2023

CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS

Canada NewsWire June 30, 2023

CHITOGENX RETAINS BRUDER CONSULTING & VENTURE GROUP TO BROADEN AND ACCELERATE ONGOING STRATEGIC DEVELOPMENT PARTNERSHIP DISCUSSIONS

Canada NewsWire June 15, 2023

Podcasts